Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Bromodomain-containing protein 3 (BRD3) or RING3-like protein (RING3L) is a protein that encodes the BRD3 gene. It plays a role in the regulation of transcription, probably by chromatin remodeling and interaction with transcription factors. It regulates transcription by promoting the binding of the transcription factor GATA1 to its targets.
The BRD3 – Drugs in Development research report provides a comprehensive overview on the therapeutics under development for BRD3, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for BRD3 and features dormant and discontinued projects.
Key Therapy Areas in the BRD3 Pipeline Drugs Market
The key therapy areas in the BRD3 pipeline drugs market are Oncology, Dermatology and Immunology.
BRD3 Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the BRD3 Pipeline Drugs Market
The key mechanism of action in the BRD3 pipeline drugs market is Bromodomain Containing Protein 3 Inhibitor.
BRD3 pipeline Drugs Market Segmentation by RoA
The key routes of administration in the BRD3 pipeline drugs market are Oral and Topical.
BRD3 pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the BRD3 pipeline Drugs Market
The key molecule type in the BRD3 pipeline drugs market is Small Molecule.
Major Companies in the BRD3 pipeline Drugs Market
The major companies in the BRD3 pipeline drugs market are Zenith Epigenetics Ltd, VYNE Therapeutics Inc, Ningbo Wenda Pharmaceutical Technology Co Ltd, Constellation Pharmaceuticals Inc, Bristol-Myers Squibb Co, Amgen Inc, and AbbVie Inc.
BRD3 pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
BRD3 Pipeline Drugs Market Overview
Key Therapy Areas | Oncology, Dermatology and Immunology |
Key Mechanisms of action | Bromodomain Containing Protein 3 Inhibitor |
Key Routes of Administration | Oral and Topical |
Key molecule types | Small Molecule |
Major companies | Zenith Epigenetics Ltd, VYNE Therapeutics Inc, Ningbo Wenda Pharmaceutical Technology Co Ltd, Constellation Pharmaceuticals Inc, Bristol-Myers Squibb Co, Amgen Inc, and AbbVie Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of BRD3
- The pipeline guide reviews pipeline therapeutics for BRD3 by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in BRD3 therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates BRD3 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for BRD3
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for BRD3
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding BRD3 pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Amgen Inc
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Co
Constellation Pharmaceuticals Inc
Ningbo Wenda Pharmaceutical Technology Co Ltd
Roivant Sciences Ltd
VYNE Therapeutics Inc
Zenith Epigenetics Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the BRD3 pipeline drugs market?
The key therapy areas in the BRD3 pipeline drugs market are Oncology, Dermatology and Immunology.
-
What are the key mechanisms of action in the BRD3 pipeline drugs market?
The key mechanisms of action in the BRD3 pipeline drugs market are Bromodomain Containing Protein 3 Inhibitor.
-
What are the key routes of administration in the BRD3 pipeline drugs market?
The key routes of administration in the BRD3 pipeline drugs market are Oral and Topical.
-
What are the key molecule types in the BRD3 pipeline drugs market?
The key molecule types in the BRD3 pipeline drugs market is Small Molecule.
-
What are the major companies in the BRD3 pipeline drugs market?
The major companies in the BRD3 pipeline drugs market are Zenith Epigenetics Ltd, VYNE Therapeutics Inc, Ningbo Wenda Pharmaceutical Technology Co Ltd, Constellation Pharmaceuticals Inc, Bristol-Myers Squibb Co, Amgen Inc, and AbbVie Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.